← Evidence library

BIB_159

DETERMINE umbrella trial — Cancer Research UK rare-cancer trial platform. NCT05770102 (atezolizumab arm), NCT05770544 (entrectinib arm), NCT05768178 (vemurafenib + cobimetinib arm). Beatson Glasgow + Edinburgh Western General sites. Banerji 2024 protocol overview. [Tasks: 16, 17] Tier: 2 Grade: A (in progress) Retrieved: 2026-05-07

Evidence grade

A

Tier

2

Cited by tasks

16, 17

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_159/findings.md (research corpus). This page is a short context summary — not individualised medical advice.